Category Archives: patient compliance

Mapping Opportunities with the Non-Physician Prescriber

They write 92% of their prescriptions without consulting a physician and are often the first provider a patient sees, and yet nurse practitioners, physician’s assistants and other non-physician prescribers (NPPs) are still somehow overlooked by pharma as an opportunity to drive sales. A GSW Worldwide report titled The non-physician prescriber will see you now points […]
Also posted in Advertising, compliance, healthcare, Marketing, Patient Communication, patient education, Sales, Strategy | Tagged , , , , , , , , , , , , | Leave a comment

The First, and Last, Word on Medication Adherence: Keep Trying!

Patient adherence to medicine is the eternal puzzle for big Pharma:  what combinations of financial incentives, personalized interventions, and just good information work best to push down that stubborn 50 per cent abandonment threshold after six months of treatment?   Certainly there are plenty of new programs on the market, so Pharm Exec believes it’s time […]
Also posted in compliance, Guest Blog | Tagged , , | 2 Comments

Changing the DNA of Pharma Patient Adherence Programs

by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors.  Pharma is also experiencing epigenetic change.  Human genes are formed from DNA, which are instructions much like a blueprint.  Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.
Also posted in compliance, E-Media, healthcare, Marketing, Patient Communication, patient education | Tagged , , , , , , | 3 Comments

Pharmacists: The Other White Coats

Patients in search of face time with a healthcare provider are stopping into their local drugstores, where consultations are free and the wait time is shorter. Pharmacists are in a unique position, too, to move the needle on drug adherence.
Also posted in compliance, E-Media, healthcare, Patient Communication, patient education, social media, Technology | Tagged , , , , | 3 Comments

Challenges in the March Toward an AIDS-Free Generation

FDA’s approval of Truvada, a once-a-day oral combination of tenofovir and emtricitabine, for pre-exposure prophylaxis (or PrEP, a method for preventing HIV infection) arrived during a chorus of optimism surrounding major developments in the fight against AIDS.
Also posted in Biotech, Events, FDA, healthcare, Market Access, Patient Communication, patient education, pricing, Regulatory, Safety | Tagged , , , , , , , | Leave a comment
  • Categories

  • Meta